NEW BRUNSWICK, N.J. — Johnson & Johnson says it has accepted an offer of about $4 billion from the private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics business.
J&J says the deal for the blood-testing unit should close by mid-year. Its shares rose in premarket trading.
The New Brunswick, N.J., health care giant said in January that Washington, D.C.-based Carlyle Group had offered $4.15 billion for the business, and that it would talk to works councils and trade unions representing its employees before making a decision.
The Ortho-Clinical business serves hospitals, testing laboratories and blood banks. It supplies equipment and chemicals to screen donated blood for HIV, hepatitis C and other serious diseases.
It also makes technology for advanced testing of blood to diagnose health conditions and to monitor medication effects.